Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan

Helicobacter

Volumn 3, Issue 1, 1998, Pages 59-63

  Suzuki, Junko ^a   Mine, Tetsuya ^a   Kobayasi, Intetsu ^b   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIULCER AGENT; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; DRUG COMBINATION; DRUG EFFECT; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; STOMACH ULCER;

ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; CAMPYLOBACTER INFECTIONS; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; OMEPRAZOLE; STOMACH ULCER;

EID: 0032014602     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.1998.08021.x     Document Type: Article

References (24)

1. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992;116:705-8.
2. Sung JJY, Chung SCC, Ling TKW et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332:139-42.
3. Weil J, Bell GD, Powell K, et al. Helicobacter pylori and metronidazole resistance. Lancet 1990; 336:1445.
4. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-6.
5. Murakami K, Fujioka T, Kubota T, et al. Evidence of Helicobacter pylori resistance to antibiotics in non-eradicated cases treated with new triple therapy. Gastroenterol 1996;110(Suppl 4):A203.
6. Jerris RC. Helicobacter. In: Murray PR, ed. Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society for Microbiology, 1995: 492-8.
7. Graham DY, Borsch GMA. The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol 1990;85:1552-5.
8. Garcia-Rodriguez JA, Garcia Sánches MI, Garcia Garcia MI, et al. In vitro activities of new oral β-lactams and macrolides against Campylobacter pylori. Antimicrob Agents Chemother 1989;33:1650-51.
9. Loo VG, Sherman P, Matlow AG. Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents. Antimicrob Agents Chemother 1992;36:1133-5.
10. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
11. Labenz J, Gyenes E, Ruhl GH, et al. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993;34:1167-70.
12. Axon ATR. The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori - an update. Scand J Gastroenterol 1994;205(Suppl):31-7.
13. Logan RPH, Gummett PA, Hegarty BT, et al. Clarithromycin and omeprazole for Helicobacter pylori. Lancet 1992;340:239.
14. Mine T, Yasuda H, Akimoto K, et al. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody. J Clin Gastroenterol 1995;20(Suppl 2):S75-8.
15. Lamouliatte H, Cayla R, Talbi P, et al. Triple therapy with PPI-amoxicillin-clarithromycin for Helicobacter pylori eradication: the optimal regimen in 1996. Gastroenterol 1996;110(Suppl 4):A171.
16. Misiewicz JJ, Harris AW, Bardhan KD, et al. One week low-dose triple therapy for eradication of H. pylori: A large multiccnter, randomized trial. Gastroenterol 1996;110(Suppl 4):A198.
17. Peitz U, Tillenburg B, Becker T, et al. Highly effective, well tolerated one-week triple therapy with omeprazole, clarithromycin and amoxicillin for Helicobacter pylori infection. Gastroenterol 1996;110(Suppl 4):A226.
18. Habu Y, Mizuno S, Kiyota K, et al. Triple therapy of omeprazole + amoxicillin + clarithromycin is effective for the cure of Helicobacter pylori infection in gastric and duodenal ulcer patients. Results of a randomized study involving 120 patients in Japan. Gastroenterol 1996;110(Suppl 4):A126.
19. Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992;29:115-20.
20. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-4.
21. Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori Antimicrob Agents Chemother 1990;34:1637-41.
22. al-Assi MT, Genta RM, Karttunen TJ, et al. Clarithromycin-amoxicillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994;8: 453-6.
23. Logan RP, Gummett PA, Shaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994;35:323-6.
24. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.